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Thyroid disease often causes menstrual disturbances and infertility problems. Thyroid hor-
mone (TH) acts through its receptors, transcription factors present in most cell types in the
body. Thyroid stimulating hormone (TSH) stimulatesTH synthesis in the thyroid gland, but
seems to have other functions as well in the female reproductive tract. The receptors of
both TH and TSH increase in the receptive endometrium, suggesting that they are impor-
tant for implantation, possible by inﬂuencing inﬂammatory mediators such as leukemia
inhibitory factor. The roles of these receptors in the ovary need further studies. However,
it is likely that the thyroid system is important for both follicular and embryo development.
The association between thyroid disease and infertility indicate that TH andTSH affect the
endometrium and ovary on the paracrine level.
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INTRODUCTION
It is well known that thyroid hormones (THs) are related to
several aspects of human reproduction. Hypo- and hyperthy-
roidism affect metabolism of sex steroids and ovarian function
in women, which is often seen as menstrual irregularities (Nor-
man and Litwack, 1987; Krassas et al., 1994, 1999). The role of TH
in infertility is less understood, although TH deﬁciency is more
common in women with polycystic ovarian syndrome (PCOS)
and to some extent also in women with infertility of unknown
cause. Very few studies exist on the paracrine effect and regulation
of THs and its receptors in the female reproductive tract. The aim
of this mini review is to summarize possible mechanisms of TH
action in female fertility.
PHYSIOLOGY OF THYROID HORMONE REGULATION
THYROID HORMONES
Thyroid hormones produced by the thyroid gland are involved
in several processes such as growth, development, differentia-
tion, and metabolism throughout the body. There are two major
types of THs, thyroxine (T4), the main secretory product and
pro-hormone for and triiodothyronine (T3), the most biologi-
cally active form (Song et al., 2011). T4 is converted to T3 using
thyroglobulin (TG), a glycoprotein and deiodinases (DOI), selene-
containing proteins that occurs in three isoforms. DOI1 and DOI2
are involved in the conversion from T4 to T3 while DOI3 catalyzes
the conversion of T4 to an inactive form of T3 (rT3; Song et al.,
2011).
Thyroid peroxidase or thyroperoxidase (TPO) is a membrane
bound hemoprotein that plays an essential role in TH synthesis
(Ris-Stalpers and Bikker, 2010). TH synthesis is stimulated by the
pituitary hormone thyroid stimulating hormone (TSH) that acts
through theG-protein-coupled TSH receptor (TSHR; Ris-Stalpers
and Bikker, 2010).
THYROID HORMONE RECEPTORS
Thyroid hormones regulate through binding to their nuclear
receptors (TRs), which have been identiﬁed in many tissues and
organs of the human body (Yen, 2001). TH receptors (TRs) belong
to the steroid/retinoid/THnuclear receptor family all having a sim-
ilar structure involving a, enhancing N-terminal transactivation
domain, a DNA-binding domain, and a carboxyl-binding ligand
binding domain (Yen, 2001). The DNA-binding domain contain
cysteine–zinc ﬁngers which binds to TH response elements on the
target genes, and the ligand binding domain is responsible for TH
binding and dimerization (Yen, 2001). Binding of THs leads to
conformational change of the receptors, chromatin modiﬁcation,
and activation of transcription (Yen, 2001). In the absence of TH,
the receptors can be bound to TRE and repress transcription (Yen,
2001). The transcriptional activity of TRs is regulated through var-
ious mechanism such as diversity of TR isoforms, several TREs,
different heterodimeric partners, a number of co-regulators, and
the cellular location of TS (Song et al., 2011).
There are two major types of TRs, TRα, and TRβ, transcribed
from different chromosomes, number 17 and number 3 respec-
tively (Lazar, 1993). Both TR isoforms mediate TH-regulated gene
expression after binding to T3. Alternative splicing of TRα gene
give rise to the either TRα1 or TRα2 or TRα3, which differ in their
carboxyl terminus due to alternative splicing (Song et al., 2011).
TRα1 binds T3 to either activate or repress target genes while the
other two splicing variants lose T3 binding capacity and antago-
nize T3 action (Izumo and Mahdavi, 1988; Mitsuhashi et al., 1988;
Macchia et al., 2001). The TRβ gene exists in three isoforms, TRβ1,
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TRβ2, and TRβ1, which differ in their amino acid terminus. All
three are able to bindT3with high afﬁnity tomediate transcription
(Hodin et al., 1989). The TRα and TRβ isoforms are ubiquitously
expressed in rat and human tissues, the distribution regulate TH
action in the target tissue (Song et al., 2011; Hodin et al., 1990;
Shahrara et al., 1999).
Non-genomic actions of THs are associated with secondary
messenger signaling pathways, and are generally occurring within
a few minutes (Losel and Wehling, 2003; Tang et al., 2004). These
effects are promoted by T4 binding to the cell surface thereby
activating MAPK complexes with TRβ1 (Davis et al., 2000).
Although THs affect a wide range of cells and tissues in the
body, they do not seem to be strictly necessary for life and only
TRβ seem to be important for fertility in mice (Forrest et al., 1996;
Wikstrom et al., 1998). TRα1 or TRβ knock-out mice are fertile
while females rarely became pregnant and were deﬁcient in nur-
turing any pups born (Forrest et al., 1996; Wikstrom et al., 1998),
which suggest that female reproductive processes in mice depend
on common pathways regulated by both TRα1 and TRβ.
CIRCULATING THYROID HORMONE
Thyroxine-binding globulin (TBG) is responsible for transporta-
tion of in circulation. It has been assumed that 75% of T4 is
bound to TBG, the rest is bound to transthyretin or albumin
or is transported as a free fraction (Tahboub and Arafah, 2009).
Endogenous estrogen (during pregnancy) or exogenous estrogen
increase serum TBG concentration as well as sex steroid binding
globulin (SHBG) while progesterone does not seem to have this
effect (Tahboub and Arafah, 2009).
HORMONAL REGULATION OF THYROID HORMONE
SECRETION
Hormonal regulation of TH synthesis involves stimulation by thy-
rotropin releasing hormone (TRH) from the hypothalamus to
synthesize TSH from the pituitary anterior pituitary gland (Wolf,
2002). TSH is regulated through TR homodimer of heterodimer-
ization with 9-cis-retinoic acid-activated retinoid X receptor bind-
ing to the TSH gene, thereby regulating the expression of the TSH
gene (Wolf, 2002). TSH stimulates thyroglobulin hydrolysis and
increase of iodinemetabolism leading to the secretion of THs from
the thyroid gland (Yen, 2001). The short- and long-term actions
of TSH in the primary regulator of T3 and T4 release and secre-
tion and plays a critical role in thyroid growth and development
(Norman and Litwack, 1987). Increased serum levels of THs leads
a negative feedback on the hypothalamus and pituitary leading to
reduced TRH and TSH secretion (Yen, 2001).
The hypothalamus produces gonadotropin-releasing hormone
(GnRH), which stimulates the pituitary gland to produce luteiniz-
ing hormone (LH) and follicle-stimulating hormone (FSH),
which in turn control the production of estradiol and proges-
terone. The hypothalamic–pituitary–thyroid axis interact with the
GnRH–LH/FSH–estradiol/progesterone (Yen, 2001).
Estrogens also have the ability to increase the number of TRH
receptors in the pituitary (Uribe et al., 2009). Because of increased
TRH production in hypothyroidism, hyperprolactinemia, and
alteredGnRHpulsatile secretion can lead to a delay in LH response
and inadequate corpus luteum function (Longcope et al., 1990).
THYROID STIMULATING HORMONE RECEPTOR
Thyroid stimulating hormone binds to the TSHR,which is a trans-
membrane receptor that belongs to the G-protein-coupled recep-
tor super family. TSHR is a key regulator of TH function (Davies
et al., 2010). Binding of TSH leads to a conformational change,
which activates the α-subunit of the heterotrimeric G-protein
thereby activating activates cAMP production and activation of
proteinkinase A, which mediates most TSH effects, especially its
short-term actions (Weiss et al., 1984; Davies et al., 2002; Dremier
et al., 2002).
Thyroid stimulating hormone receptor is not only located in
human thyroid tissue (Mizukami et al., 1994), extra-thyroidal
TSHR expression has been noticed in a variety of cell types such
as kidney, thymus, cardiac muscle, and adipose tissue cells (Davies
et al.,2002). TSH treatment leads toup-regulationof THSRmRNA
(Huber et al., 1991, 1992).
THYROID HORMONE DISEASE
HYPOTHYREOSIS
The incidence of thyroid disorders increases with age and is
more common in women than in men (Premawardhana and
Lazarus, 2006). In developed countries, autoimmune thyroid dis-
ease (AITD), which includes subclinical hypothyroidism mainly
Hashimoto’s thyroiditis and overt hypothyroidism, is the most
common cause of thyroid deﬁciency and affects 5–15% among
the women in reproductive age (Vanderpump et al., 1995; Jacob-
son et al., 1997; Wang and Crapo, 1997). AITD is characterized
by the presence of autoantibodies against thyroglobulin (TG) or
TPO. Hypothyroidism is seen as an increase in serum TSH levels
and decrease in serum T4 concentration as a result of negative
feedback. Thyroxin is the standard treatment of these women.
Hypothyroidism it is demonstrated by menorrhagia or oligomen-
orrhea, pregnancy loss and/or infertility (Krassas et al., 1999),
the severity correlated with THS concentration in serum (Krassas
et al., 1999).
There are suggestions on restricting the upper limit of nor-
mal serum TSH to TSH to 2.5 mIU/L (Poppe et al., 2007; Dittrich
et al., 2009), however there is no consensus among thyroidologists
regarding the most appropriate upper limit of normal for serum
TSH.A recent study involving 1054 IVF cycles,nodifferences in the
rates of clinical pregnancy, delivery, or miscarriage were observed
(Reh et al., 2010).
INFERTILITY
The prevalence of AITD is higher among infertile women com-
pared to fertile women (Joshi et al., 1993; Kaider et al., 1999; Grassi
et al., 2001; Poppe et al., 2002; Premawardhana and Lazarus, 2006;
Krassas et al., 2010), and a screening for thyroid dysfunction has
been suggested (Poppe et al., 2008). However, most studies fail to
demonstrate a connection between AITD and infertility (Rous-
sev et al., 1996; Lincoln et al., 1999; Kutteh et al., 1999; Arojoki
et al., 2000; Reimand et al., 2001), which might be due to higher
prevalence of subclinical hypothyreosis without thyroid antibod-
ies in often seen in patients with infertility (Negro et al., 2005;
Abalovich et al., 2007), and that treatment with levothyroxine
does not increase pregnancy or delivery rate (Negro et al., 2005). A
Finnish study including 335 infertilewomendemonstratedhighest
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TSH levels in women with unexplained infertility (Arojoki et al.,
2000).
Considering that signiﬁcantly higher serum TSH and the inci-
dence of TPO antibodies is higher in infertile women compared
to fertile controls (Poppe and Velkeniers, 2003), which indicate
that AITD predispose for infertility disorders such as PCOS and
endometriosis.
POLYCYSTIC OVARIAN SYNDROME
The prevalence of AITD is higher in women with PCOS compared
with healthy fertile women (Gerhard et al., 1991; Poppe andVelke-
niers, 2003; Janssen et al., 2004; Kachuei et al., 2012). Mueller et al.
(2009) found a signiﬁcant association between thyroid function,
as reﬂected by TSH ≥2 mIU/L, and insulin resistance in patients
with PCOS. Polymorphism in TH associated protein, a co-factor
in TR regulation, could also offer an explanation to the relation
between PCOS and the thyroid system (Goodarzi et al., 2012).
High anti-TPO resulted in clomiphene citrate resistance and poor
treatment response during fertility treatment of PCOS patients
(Ott et al., 2010).
ENDOMETRIOSIS
Poppe et al. (2002) showed in a prospective study that the rela-
tive risk of endometriosis was signiﬁcantly increased in women
positive for TPO antibodies, while other studies fail to show a
connection between AITD and endometriosis (Petta et al., 2007).
TRH is reduced in endometrium from women with endometrio-
sis compared to health controls, and epigenetic changes, e.g.,
methylation pattern and transcriptional repression inﬂuence TH
pathway by activation of TH in the endometrium from women
with endometriosis (Aghajanova and Giudice, 2011; Zelenko et al.,
2012).
HYPERTHYROIDISM
Hyperthyroidism is characterized by suppressed TSH and ele-
vated T3 and T4, most commonly seen in women of repro-
ductive age is Grave’s disease. The prevalence of Grave’s dis-
ease is 0.4–1.6% in developed countries (Furszyfer et al., 1972;
Tunbridge et al., 1977; Jacobson et al., 1997; Aghini-Lombardi
et al., 1999) The exact impact on Grave’s disease remains ill-
deﬁned as most data derives from retrospective cohort stud-
ies (Krassas et al., 1999), genetic variation in the TSHR gene
has been associated with Grave’s disease (Davies et al., 2010).
Like hypothyroidism, hyperthyroidism also leads to menstrual
disturbances, often seen as oligomenorrhea (Goldsmith et al.,
1952).
Hyperthyreosis leads to increased levels of SHBG and an
increase in total estradiol without change in free estradiol levels
(Akande and Hockaday, 1972). The conversion ratio of the andro-
gens androstenedione and testosterone to estrone and estradiol
respectively is increased in hyperthyroid women (Southren et al.,
1974; Krassas and Pontikides, 2005). In addition, the patients also
have altered GnRH-induced LH secretion, which is shown by that
serum levels of LH is increased and the pulsatile pattern of LH
seem to be disturbed, leading to changes in menstrual pattern
(Akande, 1974).
THYROID DISORDERS AND MISCARRIAGE
The presence of AITD increases the incidence of ﬁrst trimester
pregnancy loss after IVF treatment (Bussen et al., 2000;Negro et al.,
2005). Thyroid treatment is beneﬁcial for women with suffering
from recurrent miscarriage (Vaquero et al., 2006). The mecha-
nism behind AITD and recurrent pregnancy has been debated.
One theory is that AITD does not have a direct effect, it is just
a marker of a general autoimmune imbalance responsible for
rejection of the fetal graft (Bussen et al., 2000). A second the-
ory is that AITD reﬂects a thyroid dysfunction with decreased
ability to adapt to the increased requirements of pregnancy (Kras-
sas et al., 1999; Bussen et al., 2000). The third is that women
with AITD have an underlying fertility problem leading to con-
ception at a later age, thereby increasing the risk of pregnancy
loss (Bussen et al., 2000). A recent study found that although
TSH was well below the conventional upper cut-off levels, less
than 1.5μIU/ml, inadequate adaptation to the increased thyroid
requirement might result in recurrent miscarriage (Dal Lago et al.,
2011).
GENETIC VARIATION AND FERTILITY
CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism was
shown to be associated with thyroid autoantibody production
in patients with Hashimoto’s and postpartum thyroiditis (Zaletel
et al., 2010).
Single nucleotide polymorphism rs4704397 in the phospho-
diesterase 8B (PDE8B) gene associated with altered serum TSH
concentrations was not associated with offspring birth weight
or gestational age at delivery (Shields et al., 2009). TRα1 muta-
tion results in repressed peroxisome proliferator-activated recep-
tor gamma (PPARgamma; Ying et al., 2007), which might
impair trophoblast invasiveness and placentation (Fournier et al.,
2011).
ENVIRONMENTAL FACTORS
Endocrine disruptors act with agonistic or antagonistic effects on
steroid hormone receptors and may alter reproductive function
and/or cause feminization by binding to estrogen or androgen
receptors. Increasing evidence show that environmental factors
such as endocrine disruptors inﬂuence reproduction in mammals,
ﬁsh, birds, reptiles, aquatic invertebrates; the effect in humans
being less studied. It has been discussed that PCBs, phthalates,
bisphenol A, brominated ﬂame retardants, and perﬂuorinated
chemicals may have thyroid disrupting properties (Boas et al.,
2011). Phthalates adversely affected the level of reproductive hor-
mones (LH, free testosterone, sex hormone-binding globulin),
anogenital distance and thyroid function (Jurewicz and Hanke,
2011), and perchlorate given to lactating rhesus monkeys sup-
pressed iodine uptake (Ozpinar et al., 2011). However, bisphenol
A in patients were signiﬁcantly higher in women with recur-
rent miscarriage than control women, without direct effect on
thyroid function (Sugiura-Ogasawara et al., 2005). The increase
in infertility rate seen in the western world might not only be
inﬂuenced by the fact that women tend to have their ﬁrst child
later in life, environmental factors inﬂuencing fertility might also
play a role.
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EXPRESSION OF THYROID HORMONE RECEPTORS IN
REPRODUCTIVE TISSUE
ENDOMETRIUM
TRα1 and TRβ1 and TSHR are expressed in human endometrium,
the highest level is seen in the receptive endometrium (Agha-
janova et al., 2011). Several paracrine factors are of importance
for successful embryo implantation, leukemia inhibitory factor
(LIF), and Leptin being among the most studied (Stewart et al.,
1992; Chehab et al., 1996; Antczak and Van Blerkom, 1997; Ciofﬁ
et al., 1997; Gonzalez et al., 2000, 2004; Kawamura et al., 2002;
Aghajanova, 2004). TSH increase LIF and LIF receptor expres-
sion in endometrial epithelial ishikawa cells and in thyroid cells
(Ren et al., 1999; Aghajanova et al., 2011). TSH releases lep-
tin in human adipose tissue culture (Menendez et al., 2003),
and it is possible that this effect is present also in the human
endometrium, thereby playing a role for successful implantation
(Figure 1).
The expression of TSH receptors leads to the question if there
is a possibility that TSH induce TH secretion from other cells than
the thyroid gland. Our recent study show increased secretion of
free triiodothyronine (T3) and total thyroxin (T4) by Ishikawa cells
compared with non-stimulated cells (Aghajanova et al., 2011), and
a previous study show that progesterone is involved in TH signal-
ing such as type II iodothyronine deiodinase and TRs, TPO, and
TG in the endometrium. Transcripts required for TH synthesis
such as thyroid peroxidase (TPO) and thyroglobulin (TG), which
further suggest that the endometrium may be a site of thyroxin
production (Catalano et al., 2007) (Figure 1).
Thyroid hormones have been suggested at modulators of
immune response such as inﬂuence on cytokines and NK-cells (De
Vito et al., 2011). CD56 positive NK cell level has been shown to be
signiﬁcantly higher in women with miscarriage (Kim et al., 2011).
Interleukins are important factors in endometrial development
and implantation. In tears from patients with thyroid-associated
ophthalmopathy, the interleukins IL-1β, IL-6, and IL-8 were sig-
niﬁcantly higher than healthy controls (Huang et al., 2011). It is
not known if TH is involved n the regulation of inﬂammatory
mediators in the endometrium (Figure 1).
Furthermore, as TSH and THs regulate glucose transport via
glucose transporters (GLUT), in particular GLUT1 (Hosaka et al.,
1992; Weinstein and Haber, 1993), which makes TH as a can-
didate for regulation of GLUT1 in decidualized endometrium,
mouse blastocysts (Pantaleon et al., 2001), and morula–blastocyst
transition in mice (Leppens-Luisier et al., 2001) (Figure 1).
Leptin has been suggested to inﬂuence the thyroidal axis by reg-
ulating the expression of TSH (Sanchez et al., 2004). Leptin and
TSH share the same pulsatile pattern reaching the highest levels
during morning hours, which might explain why some individ-
uals with leptin deﬁciency have abnormal TSH secretion pattern
(Mantzoros et al., 2001). However, most individuals with leptin
deﬁciency have normal TSH levels (Legradi et al., 1997; Paz-Filho
et al., 2009).
OVARY
Thyroid hormones are present in follicular ﬂuid and TRs are
present in granulosa cells (Wakim et al., 1993, 1994; Aghajanova
FIGURE 1 | Possible interaction between the embryo and endometrium is shown.The thyroid system is involved in the regulation of LIF and interleukins,
key factors for successful implantation.
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et al., 2009) and in primordial, primary, and secondary follicles
(Aghajanova et al., 2009). Mature (MII) oocytes from women
undergoing IVF demonstrate the presence of TRα1, TRα2, TRβ1,
and TRβ2 mRNA, supporting the hypothesis that T3 has a direct
effect on the human oocyte (Zhang et al., 1997). Our study
show TSHR, TRα1, and TRβ1 and deiodinases types 2 and 3
in combination with activation of cAMP by TSH indicates a
possibility of conversion of peripheral T4 on ovarian tissue (Agha-
janova et al., 2009). Failure of oocytes to get fertilized during IVF
treatment was correlated with increased TSH in serum (Cramer
et al., 2003). Development of bovine embryos was shown to
beneﬁt from TH-treatment (Ashkar et al., 2010). TH-treatment
of embryos increased bovine blastocyst formation and hatching
rates as well post-cryopreservation viability (Ashkar et al., 2010).
Despite this, no difference in TR was seen during development
of human embryo indicating that THs are important throughout
development (Zhang et al., 2009).
In cases of hyperthyroidism, the ultrasonography appearance
of the ovaries showed an abnormal size, form, and number of
follicle. The appearance became normal after treatment (Skjolde-
brand Sparre et al., 2002). Multicystic ovaries during profound
hypothyroidism has also been noticed (Van Voorhis et al., 1994),
which suggest a direct effect of THs on the ovary (Maruo et al.,
1992). High TSH was also seen in women with ovulatory dysfunc-
tion compared with tubal infertility and male infertility (Arojoki
et al., 2000).
Thyroid stimulating hormone receptor in the ovary is up-
regulated by gonadotropin-driven cascade and down-regulated by
estradiol. The relatively recently discovered glycoprotein thyros-
timulin is expressed in the ovary andwas shown to activate ovarian
TSH receptor expression, suggesting a paracrine regulation of
thyroid function in the rat ovary (Sun et al., 2010).
CONCLUSION
Thyroid hormone as well as TSH seem to involved in regulation
of the endometrium to a receptive phase and is thereby also likely
to play a role during embryo implantation. Of special interest is
the role of THs on inﬂammatory mediators such as LIF, one of
the most important cytokines in female reproduction. Further-
more, TH as well as TSH seem to play an important role in normal
ovarian function, which clinically evident in the relation between
PCOS and thyroid disease.
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